fundvisualizer.com

Neuberger Berman International Eq ANIQAX

Performance (before sales charge)

As of 09/30/2024

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 09/30/2024
Stock
4.29%
Non-U.S. Stock
93.61%
Bond
1.20%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
0.90%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 09/30/2024

Basic materials

3.74%

Consumer cyclical

4.91%

Financial services

17.09%

Real estate

0.00%

Consumer defensive

7.18%

Health care

16.39%

Utilities

0.00%

Communication services

3.03%

Energy

2.21%

Industrials

24.50%

Technology

18.85%

Top 10 holdings

As of 09/30/2024

ASML Holding NV
2.79%
Novo Nordisk AS Class B
2.18%
AstraZeneca PLC
2.12%
Experian PLC
1.95%
Unilever PLC
1.93%
Hitachi Ltd
1.92%
London Stock Exchange Group PLC
1.90%
Oracle Corp Japan
1.84%
Symrise AG
1.60%
DSV AS
1.58%
Fund assets

$1.11 Billion

Share class

A

Morningstar category

Foreign Large Blend

Expense ratio

1.23%

Investment objective

Foreign Stock

Documents